MoneyWorks4Me

Auro Laboratories - Quaterly Results

28 Jan 2022 Evaluate
The sales declined to Rs. 121.37 millions for the December 2021 quarter as compared to Rs. 131.09 millions during the corresponding quarter last year.The Company to register a -70.00%  fall in the net profit for the quarter ended December 2021.The company reported a degrowth in operating Profit to 12.39 millions from 31.13 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 121.37 131.09 -7.41 329.83 406.88 -18.94 542.52 437.91 23.89
Other Income 0.21 2.50 -91.60 8.10 5.86 38.23 7.58 9.73 -22.10
PBIDT 12.39 31.13 -60.20 45.32 87.93 -48.46 120.00 72.43 65.68
Interest 1.65 0.49 236.73 4.30 2.09 105.74 4.58 5.78 -20.76
PBDT 10.74 30.64 -64.95 41.02 85.84 -52.21 115.42 66.65 73.17
Depreciation 2.60 2.60 0.00 7.80 7.60 2.63 10.36 10.23 1.27
PBT 8.14 28.04 -70.97 33.22 78.24 -57.54 105.06 56.42 86.21
TAX 2.04 7.71 -73.54 9.34 21.52 -56.60 33.26 15.87 109.58
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 1.25 0.62 101.61
PAT 6.10 20.33 -70.00 23.88 56.72 -57.90 71.80 40.55 77.07
Equity 62.33 62.33 0.00 62.33 62.33 0.00 62.32 62.32 0.00
PBIDTM(%) 10.21 23.75 -57.01 13.74 21.61 -36.42 22.12 16.54 33.73
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..